Endobiliary Radiofrequency Ablation Combined with Gemcitabine and Cisplatin in Patients with Unresectable Extrahepatic Cholangiocarcinoma

Background: Endobiliary radiofrequency ablation (RFA) is a promising treatment modality for patients with extrahepatic cholangiocarcinoma (eCCA). However, no study has investigated the combined use of endobiliary RFA and gemcitabine plus cisplatin (GC) chemotherapy. This study aimed to examine the f...

Descripción completa

Detalles Bibliográficos
Autores principales: Inoue, Tadahisa, Naitoh, Itaru, Kitano, Rena, Ibusuki, Mayu, Kobayashi, Yuji, Sumida, Yoshio, Nakade, Yukiomi, Ito, Kiyoaki, Yoneda, Masashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029596/
https://www.ncbi.nlm.nih.gov/pubmed/35448156
http://dx.doi.org/10.3390/curroncol29040182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029596/
https://www.ncbi.nlm.nih.gov/pubmed/35448156
http://dx.doi.org/10.3390/curroncol29040182

Ejemplares similares